Jiangsu Hengrui Pharmaceuticals Co. has started taking investor orders for a Hong Kong listing that could raise as much as ...

SYDNEY (Reuters) -Chinese battery maker CATL is set to price its shares at HK$263 ($33.70) each in the company's Hong Kong ...

Proportion of respiratory samples testing positive increased 7.5% in four weeks, but health expert claims overall impact of ...

By Scott Murdoch (Reuters) -Chinese battery manufacturer CATL aims to raise at least HK$31.01 billion ($3.99 billion) in its ...

Hong Kong-based lender Hang Seng Bank said on Thursday that it was restructuring its business and streamlining duplicate ...

Singapore-based medical testing firm Mirxes joins Jiangsu Hengrui Pharmaceuticals in revitalised market’s listing surge.

China-based Jiangsu Hengrui Pharmaceuticals is seeking to raise up to HK$9.89 billion ($1.27 billion) in a Hong Kong initial public offering, according to a regulatory filing made on Thursday.

HK's legislature will form a subcommittee to oversee 2 new pieces of subsidiary legislation under the city’s homegrown ...

HK's proposed ban on traditional smoking products with added flavourings is not "over the top," the gov't has said, adding ...

HONG KONG — HONG KONG — Alibaba Group Holding Ltd. (BABA) on Thursday reported fiscal fourth-quarter net income of $1.71 billion. On a per-share basis, the Hong Kong-based company said it had profit ...

SINGAPORE] Singapore biotech start-up Mirxes launched its initial public offering (IPO) in Hong Kong on Thursday (May 15) as ...

The FT’s former arts editor picks the greatest hits of a young gallery that houses a major collection of East Asian modern art and design ...